There are currently 45 active clinical trials seeking participants for Migraine research studies. The states with the highest number of trials for Autism participants are Florida, California, Texas and New York.
Family Study of Affective and Anxiety Spectrum Disorders
NCT00071786
Recruiting
This study will examine how depression, anxiety, and migraine run in families. It will help in defining the risk factors for physical, mental, and health problems-as well as define ways that those problems may be prevented and treated. A broad range of ages among family members will be included to evaluate the patterns of how these disorders are expressed throughout people's lives. Children of all ages will be included, and those ages 8 to 17 will be interviewed directly. Assessments will be c... Read More
Gender:
All
Ages:
Between 7 years and 120 years
Trial Updated:
02/17/2024
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Mood Disorders, Sleep Disorders, Migraine
Register for Updates
Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy
NCT05198245
Recruiting
The purpose of the study is to evaluate the risk of pregnancy and infant outcomes among women with migraine exposed to rimegepant during pregnancy and in two rimegepant unexposed comparator groups.
Gender:
Female
Ages:
Between 16 years and 49 years
Trial Updated:
02/15/2024
Locations: Research Triangle Institute d/b/a RTI Health Solutions, Research Triangle Park, North Carolina
Conditions: Migraine
Register for Updates
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
NCT05046613
Recruiting
The purpose of the study is to evaluate fetal, maternal, and infant outcomes through 12 months of age.
Gender:
Female
Ages:
18 years and above
Trial Updated:
02/15/2024
Locations: PPD, Morrisville, North Carolina
Conditions: Migraine
Register for Updates
Sequential, Multiple Assignment, Double Randomized Preference, Migraine Behavioral Trial
NCT06170281
Recruiting
This study will unpack the behavioral intervention for migraine and determine the optimum combinations. In addition, the study will test preference and self-selection effects during the trial.
Gender:
All
Ages:
18 years and above
Trial Updated:
01/26/2024
Locations: Stanford University, Stanford, California
Conditions: Migraine, Headache, Chronic Migraine, Headache Disorders
Register for Updates
Mi-Helper Transnasal Cooling for Acute Treatment of Migraine
NCT06051604
Recruiting
This is a prospective, double-blind, sham-controlled, randomized two-part clinical trial with an adaptive design. This study aims to assess the efficacy, safety, tolerability, and the optimal dose of the Mi-Helper transnasal cooling device for acute treatment of migraine in an at home setting. This study will be conducted in two parts. The first part of this study aims to determine the most effective dose of Mi-Helper and the second part aims to evaluate the efficacy, safety, and tolerability o... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
11/29/2023
Locations: ObvioHealth, New York, New York
Conditions: Episodic Migraine, Migraine With Aura, Migraine Without Aura, Migraine
Register for Updates
Emgality for Migraine in Breastmilk
NCT06085144
Recruiting
The goal of this project is to evaluate galcanezumab transfer into maternal breastmilk, and to evaluate infant (growth, development, constipation, colic, infections) and maternal (headache) outcomes for dyads in which the mother was treated with galcanezumab and to compare outcomes for infants who were or were not breastfed after maternal treatment. In this prospective observational study, the study team proposes to prospectively collect serial milk samples from 30 adult women who are treated w... Read More
Gender:
Female
Ages:
Between 18 years and 45 years
Trial Updated:
11/28/2023
Locations: University of California, San Francisco, San Francisco, California
Conditions: Migraine
Register for Updates
Aimovig Pregnancy Exposure Registry
NCT06150781
Recruiting
The primary objective of this study is to estimate the proportion of major congenital malformations in infants of women with migraine exposed to erenumab-aooe during pregnancy compared to infants of women with migraine unexposed to erenumeb-aooe.
Gender:
Female
Ages:
Between 18 years and 99 years
Trial Updated:
11/21/2023
Locations: IQVIA Virtual Site, Durham, North Carolina
Conditions: Migraine
Register for Updates
RELAXaHEAD for Headache Patients (Phase III)
NCT06077838
Recruiting
This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.
Gender:
All
Ages:
Between 16 years and 80 years
Trial Updated:
11/06/2023
Locations: NYU Langone Health, New York, New York
Conditions: Migraine
Register for Updates
NIMH Rhythms and Blues Study: A Prospective Natural History Study of Motor Activity, Mood States, and Bipolar Disorder
NCT05669703
Recruiting
Background: Mood disorders, such as bipolar disorder, can have serious effects on a person s life. People with bipolar disorder are more likely to have heart disease and abuse substances. In this natural history study, researchers would like to learn more about the connection between exercise and mental health in people with and without mood disorders. Objective: To better understand relationships among physical activity, sleep, and mental health. Eligibility: People aged 12 to 60 years wit... Read More
Gender:
All
Ages:
Between 12 years and 70 years
Trial Updated:
11/06/2023
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland
Conditions: Bipolar Disorder, Major Depression, Migraine
Register for Updates
Telehealth Behavioral Migraine Management
NCT03982316
Recruiting
This project aims to develop the protocol and obtain feasibility and acceptability information for Telehealth Behavioral MIgraine Management in a single-arm pre-post pilot study. The investigator and study team aim to recruit 20 people with migraine from the Montefiore Headache Center in the Bronx NY. Participants will receive the 12-week protocol including a mobile app headache diary, an online patient manual with interactive vignettes, 4 50-minute telehealth sessions, and 3 15-minute check-ins... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/30/2023
Locations: Albert Einstein College of Medicine, Bronx, New York
Conditions: Migraine
Register for Updates
Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine
NCT05175521
Recruiting
The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
10/18/2023
Locations: HonorHealth Bob Bové Neuroscience Institute, Scottsdale, Arizona
Conditions: Migraine
Register for Updates
An Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult Participants
NCT05653986
Recruiting
Migraine is a neurological disease characterized by moderate or severe headache, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will how effective the combination use of ubrogepant and atogepant is in treating adult participants with migraine. Change in migraine activity will be assessed. Urogepant (Ubrelvy) and Atogepant (Qulipta) are approved drugs for treatment of migraine in adults in the US. Approximately 432 adult participants who are prescribed Ubroge... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
10/02/2023
Locations: Montefiore/Albert Einstein /ID# 252243, Bronx, New York
Conditions: Migraine
Register for Updates